🇺🇸 FDA

Company profile · Sponsor

Rocket

Rocket Pharmaceuticals B.V.

RCKT · NYSE pharma NEW YORK, NY, EU
Pipeline
11
Drugs
1
Patents
1

Quick answer

Rocket (RCKT) is a pharma company. headquartered in NEW YORK, NY, EU. listed on NYSE. NovaPharmaNews links 11 pipeline programs, 1 drug, and 1 patent to this profile..

Company facts

Ticker RCKT
Exchange NYSE
Company type pharma
Headquarters NEW YORK, NY, EU
SEC CIK 0001281895

Pipeline (11)

Search pipeline →

  1. RP-A501

    Rocket

    Danon Disease

    phase 2 gene therapy active

    2 trials

  2. RP-L102

    Rocket

    Fanconi Anemia Complementation Group A

    phase 2 mab active

    3 trials

  3. RP-L201

    Rocket

    Leukocyte Adhesion Defect - Type I

    phase 2 mab completed

    2 trials

  4. RP-L301

    Rocket

    Pyruvate Kinase Deficiency

    phase 2 mab on hold

    2 trials

  5. Filgrastim

    Rocket

    Fanconi Anemia

    phase 1 mab terminated

    1 trial

  6. RP-A601

    Rocket

    PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

    phase 1 gene therapy active

    1 trial

  7. RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, BCL2-associated Athanogene 3 (BAG3)

    Rocket

    Dilated Cardiomyopathy (DCM)

    phase 1 gene therapy active

    1 trial

  8. RP-L401

    Rocket

    Infantile Malignant Osteopetrosis

    phase 1 mab terminated

    1 trial

  9. SIS-reinforced anastomosis

    Rocket

    Rectal Cancer

    approved other active

    1 trial

  10. Xuebijing

    Rocket

    Pulmonary Disease, Chronic Obstructive

    approved small molecule active

    1 trial

  11. Clostridium butyricum (live) Tablets(Meiya)

    Rocket

    Rectal Cancer

    mab active

    1 trial

Drugs (1)

Search drugs →

  1. mozafancogene autotemcel

    FANSKYA

Patents (1)

Search patents →

  1. US 10703797

    Gene therapy vectors for treatment of Danon disease

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Rocket?

Rocket (RCKT) is a pharma company. headquartered in NEW YORK, NY, EU. listed on NYSE. NovaPharmaNews links 11 pipeline programs, 1 drug, and 1 patent to this profile..

What pipeline programs does Rocket sponsor?

We track 11 ClinicalTrials.gov-linked programs for Rocket, including RP-A501 and 10 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Rocket company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.